Figure 7

Serum Triglycerides changes during and after treatment. Forest plot for mean difference (MD) and 95% confidence intervals (CI) for each time-point. DCV/ASV daclatasvir/asunaprevir, SOF/LDV sofosbuvir/ledipasvir, PrOD paritaprevir/ritonavir/ombitasvir + dasabuvir, SOF/DCV sofosbuvir + daclatasvir, SVR12 Sustained virological response at 12 weeks, SVR24 Sustained virological response at 24 weeks.